期刊文献+

血管内皮生长因子在胎儿生长受限患者及胎儿脐血中的表达 被引量:3

The expression of VEGF in both patients and cord blood of FGR
原文传递
导出
摘要 目的检测胎儿生长受限(FGR)患者外周血中血管内皮生长因子(VEGF)的水平,并探讨其与FGR的关系。方法2002年1月至2004年1月汕头大学医学院第二附属医院应用双抗体酶联免疫吸附法(ELISA)检测晚期正常妊娠妇女(妊娠组,30例)以及FGR(FGR组,37例)母体外周血中VEGF的水平和脐血中的VEGF水平。结果(1)正常孕晚期母体外周血VEGF为(753±157)ng/L,新生儿脐血VEGF为(1074±343)ng/L;(2)FGR组母体外周血VEGF水平(424±137)ng/L,新生儿脐血VEGF水平为(745±243)ng/L。FGR组母体外周血和新生儿脐带血中VEGF均明显低于妊娠组孕晚期水平(P<0001)。结论妊娠晚期VEGF水平显著下降可能是FGR发病机制中的一个重要因素。
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2005年第4期225-226,共2页 Chinese Journal of Practical Gynecology and Obstetrics
  • 相关文献

参考文献6

  • 1Petersen TM, Larsen T, Nielsen HI. Angiogenie proteins: possible markers of physiopathologieal processes during fetal development Ugeskr Laeger,2003,165 (32) :3082-3087.
  • 2Tse JY, Lao rlT, Chart CC, et al. Expression of vascular endothelial growth factor in third-trimester placentas is not increased in growthrestricted fetuses. J Soc Gynecol Investig,2001,8(2) :77-82.
  • 3Regnault TR, Orbus RJ, de Vrijer B, et al. Placental expression ofVEGF, P1GF and their receptors in a model of placental insufficiency-intrauterine growth restriction (PI-IUGR). Placenta,2002,23 ( 2-3 ) : 132-144.
  • 4Helske S, Vuorela P, Carpen O, et al. Expression of vascular endothelial growth factor receptors 1,2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod, 2001,7 ( 2 ) : 205-210.
  • 5Bartha JL, Romero-Carmona R, Escobar-Llompart M, et al. Human chorionic gonadotropin and vascular endothelial growth factor in normal and complicated pregnancies. Obstet Gynecol, 2003,102 (5 Pt1) :995-999.
  • 6Jojovic M, Wolf F, Mangold U. Epidermal growth factor, vascular endothelial growth factor and progesterone promote placental development in rat whole embryo culture. Anat Embryo Berl, 1998,198:133-139.

同被引文献31

  • 1陈廉,谢兰,罗军,邹冰玉.妊娠高血压综合征血管内皮生长因子表达与围产儿结局的关系[J].实用医院临床杂志,2005,2(2):30-32. 被引量:1
  • 2傅勤,林建华.血管内皮生长因子在子痫前期发病机制中的研究[J].国外医学(妇产科学分册),2006,33(1):23-26. 被引量:5
  • 3李丽丹,冯玲.血管内皮生长因子(VEGF)与妊娠的研究进展[J].中国优生与遗传杂志,2007,15(2):3-4. 被引量:14
  • 4Petersen TM , Larst L , Nielsen HJ. Angiogenic proteins: possible markers of hysiopathological processes during fetal development [ J ]. Ugeskr Laeger,2003,165 ( 32 ) :3082 - 3087.
  • 5O Reilly MS,Boehm T,Shing Y,et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth[ J]. Cell, 1997, 88: 277.
  • 6Dhanabal M, et al. Endostatin induces endothelial cell apoptosis [ J ]. J Biol Chem, 1999, 274:11721 -11726.
  • 7Chang Z, Choon A, Ffiedl A. Endostatin binds to blood veaaels in situ independent of heparan sulfaet and does not compete for fibroblast growth factor - 2 binding[ J]. Am J Pathol, 1999,155:71.
  • 8Streit M, Velasco P, Brown LF, et al. Overexpression of thrombospondin - 1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas[ J]. Am J Pathol, 1999, 155(2) :441 -4-52.
  • 9Standker L, Schrader M, Kanse SM, et al. Isolation and characterrization of circulating form of human endostatin [ J ]. FEBS Lett, 1997,420: 129 - 133.
  • 10Urbich C, Reissner A, Chavakis E, et al. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti - angiogenic effects of endostatin[J]. FASEB J, 2003, 16:706 -708.

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部